204 related articles for article (PubMed ID: 37088137)
1. Next-Generation Sequencing-Based Genomic Profiling of Children with Acute Myeloid Leukemia.
Krizsán S; Péterffy B; Egyed B; Nagy T; Sebestyén E; Hegyi LL; Jakab Z; Erdélyi DJ; Müller J; Péter G; Csanádi K; Kállay K; Kriván G; Barna G; Bedics G; Haltrich I; Ottóffy G; Csernus K; Vojcek Á; Tiszlavicz LG; Gábor KM; Kelemen Á; Hauser P; Gaál Z; Szegedi I; Ujfalusi A; Kajtár B; Kiss C; Matolcsy A; Tímár B; Kovács G; Alpár D; Bödör C
J Mol Diagn; 2023 Aug; 25(8):555-568. PubMed ID: 37088137
[TBL] [Abstract][Full Text] [Related]
2. Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR-ABL1, a Swedish population-based study.
Orsmark-Pietras C; Landberg N; Lorenz F; Uggla B; Höglund M; Lehmann S; Derolf Å; Deneberg S; Antunovic P; Cammenga J; Möllgård L; Wennström L; Lilljebjörn H; Rissler M; Fioretos T; Lazarevic VL
Genes Chromosomes Cancer; 2021 Jun; 60(6):426-433. PubMed ID: 33433047
[TBL] [Abstract][Full Text] [Related]
3. Gene mutation analysis using next-generation sequencing and its clinical significance in patients with myeloid neoplasm: A multi-center study from China.
Li J; Pei L; Liang S; Xu S; Wang Y; Wang X; Liao Y; Zhan Q; Cheng W; Yang Z; Tang X; Zhang H; Xiao Q; Chen J; Liu L; Wang L
Cancer Med; 2023 Apr; 12(8):9332-9350. PubMed ID: 36799265
[TBL] [Abstract][Full Text] [Related]
4. Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets.
Stratmann S; Yones SA; Mayrhofer M; Norgren N; Skaftason A; Sun J; Smolinska K; Komorowski J; Herlin MK; Sundström C; Eriksson A; Höglund M; Palle J; Abrahamsson J; Jahnukainen K; Munthe-Kaas MC; Zeller B; Tamm KP; Cavelier L; Holmfeldt L
Blood Adv; 2021 Feb; 5(3):900-912. PubMed ID: 33560403
[TBL] [Abstract][Full Text] [Related]
5. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L
Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340
[TBL] [Abstract][Full Text] [Related]
6. Whole-exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia.
Shiba N; Yoshida K; Shiraishi Y; Okuno Y; Yamato G; Hara Y; Nagata Y; Chiba K; Tanaka H; Terui K; Kato M; Park MJ; Ohki K; Shimada A; Takita J; Tomizawa D; Kudo K; Arakawa H; Adachi S; Taga T; Tawa A; Ito E; Horibe K; Sanada M; Miyano S; Ogawa S; Hayashi Y
Br J Haematol; 2016 Nov; 175(3):476-489. PubMed ID: 27470916
[TBL] [Abstract][Full Text] [Related]
7. Genomic Profiling of Pediatric Acute Myeloid Leukemia Reveals a Changing Mutational Landscape from Disease Diagnosis to Relapse.
Farrar JE; Schuback HL; Ries RE; Wai D; Hampton OA; Trevino LR; Alonzo TA; Guidry Auvil JM; Davidsen TM; Gesuwan P; Hermida L; Muzny DM; Dewal N; Rustagi N; Lewis LR; Gamis AS; Wheeler DA; Smith MA; Gerhard DS; Meshinchi S
Cancer Res; 2016 Apr; 76(8):2197-205. PubMed ID: 26941285
[TBL] [Abstract][Full Text] [Related]
8. What Is Abnormal in Normal Karyotype Acute Myeloid Leukemia in Children? Analysis of the Mutational Landscape and Prognosis of the TARGET-AML Cohort.
Herlin MK; Yones SA; Kjeldsen E; Holmfeldt L; Hasle H
Genes (Basel); 2021 May; 12(6):. PubMed ID: 34064268
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and prognostic significance of genetic mutations in acute myeloid leukemia based on a targeted next-generation sequencing technique.
Wang RQ; Chen CJ; Jing Y; Qin JY; Li Y; Chen GF; Zhou W; Li YH; Wang J; Li DW; Zhao HM; Wang BH; Wang LL; Wang H; Wang MZ; Gao XN; Yu L
Cancer Med; 2020 Nov; 9(22):8457-8467. PubMed ID: 32970934
[TBL] [Abstract][Full Text] [Related]
10. Difference in gene mutation profile in patients with refractory/relapsed versus newly diagnosed acute myeloid leukemia based on targeted next-generation sequencing.
Wang M; Wang R; Wang H; Chen C; Qin J; Gao X; Yu L
Leuk Lymphoma; 2021 Oct; 62(10):2416-2427. PubMed ID: 33913388
[TBL] [Abstract][Full Text] [Related]
11. Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing.
Masetti R; Castelli I; Astolfi A; Bertuccio SN; Indio V; Togni M; Belotti T; Serravalle S; Tarantino G; Zecca M; Pigazzi M; Basso G; Pession A; Locatelli F
Oncotarget; 2016 Aug; 7(35):56746-56757. PubMed ID: 27462774
[TBL] [Abstract][Full Text] [Related]
12. Mutational profiling of acute myeloid leukemia with normal cytogenetics in Brazilian patients: the value of next-generation sequencing for genomic classification.
de Noronha TR; Mitne-Neto M; Chauffaille ML
J Investig Med; 2017 Dec; 65(8):1155-1158. PubMed ID: 28923882
[TBL] [Abstract][Full Text] [Related]
13. [Using next generation sequencing technology to analyze gene mutations in patients with acute myeloid leukemia and the impact on prognosis].
Zhao CX; Wang JM; Li JM; Zou SH; Chen FY; Liang AB; Hou J; Hu XX; Zhang YX; Gu SY; Zhu JY; Li P; Du J; Yang YN; Qin YW; Wang XR; Wang C
Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3145-3151. PubMed ID: 31694105
[No Abstract] [Full Text] [Related]
14. Next-generation sequencing reveals gene mutations landscape and clonal evolution in patients with acute myeloid leukemia.
Chen X; Zhu H; Qiao C; Zhao S; Liu L; Wang Y; Jin H; Qian S; Wu Y
Hematology; 2021 Dec; 26(1):111-122. PubMed ID: 33491606
[TBL] [Abstract][Full Text] [Related]
15. Incidences and Prognostic Impact of c-KIT, WT1, CEBPA, and CBL Mutations, and Mutations Associated With Epigenetic Modification in Core Binding Factor Acute Myeloid Leukemia: A Multicenter Study in a Korean Population.
Park SH; Lee HJ; Kim IS; Kang JE; Lee EY; Kim HJ; Kim YK; Won JH; Bang SM; Kim H; Song MK; Chung JS; Shin HJ
Ann Lab Med; 2015 May; 35(3):288-97. PubMed ID: 25932436
[TBL] [Abstract][Full Text] [Related]
16. Panel-based next-generation sequencing facilitates the characterization of childhood acute myeloid leukemia in clinical settings.
Ishida H; Iguchi A; Aoe M; Nishiuchi R; Matsubara T; Keino D; Sanada M; Shimada A
Biomed Rep; 2020 Nov; 13(5):46. PubMed ID: 32934818
[TBL] [Abstract][Full Text] [Related]
17. An NGS based MRD evaluation from acute myeloid leukemia patients.
Chen B; Wang L; Wang Z; Zhang H; Chen L; Zhang L; Li J; Yan X; Zhao M; Lin Y; Ru K
Int J Lab Hematol; 2023 Jun; 45(3):353-359. PubMed ID: 36751002
[TBL] [Abstract][Full Text] [Related]
18. Mutational landscape and clinical outcome of pediatric acute myeloid leukemia with 11q23/KMT2A rearrangements.
Yuen KY; Liu Y; Zhou YZ; Wang Y; Zhou DH; Fang JP; Xu LH
Cancer Med; 2023 Jan; 12(2):1418-1430. PubMed ID: 35833755
[TBL] [Abstract][Full Text] [Related]
19. Molecular evaluation of gene mutation profiles and copy number variations in pediatric acute myeloid leukemia.
Meena JP; Pathak N; Gupta AK; Bakhshi S; Gupta R; Makkar H; Seth R
Leuk Res; 2022 Nov; 122():106954. PubMed ID: 36162216
[TBL] [Abstract][Full Text] [Related]
20. Laboratory evaluation and prognostication among adults and children with CEBPA-mutant acute myeloid leukemia.
Mendoza H; Podoltsev NA; Siddon AJ
Int J Lab Hematol; 2021 Jul; 43 Suppl 1():86-95. PubMed ID: 34288448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
